Impact of muitidrug resistance 1 gene polymorphisms on Tacrolimus regimen and outcome of grafts in renal transplantation recipients
- Author:
- No author available
- Journal Title:
- Chinese Journal of Organ Transplantation
- Issue:
- 3
- DOI:
- 10.3760/cma.j.issn.0254-1785.2012.03.002
- Key Word:
- 肾移植;多药耐药相关蛋白质类;多态性,单核苷酸;他克莫司;Kidney transplantation;Multidrug resistance-associated proteins;Polymorphism,single nucleotide;Tacrolimus
Abstract： Objective To investigate the effect of the polymorphisms of multidrug resistance 1 (MDR1) C3435T and G2677T on Tacrolimus (Tac) individualized treatment and prognosis of grafts in the renal transplantation recipients (RTRs).Methods One hundred and twenty-seven RTRs who treated with Tac regimen and had a stable graft function were enrolled,and were divided into adjuvant treatment group and non-adjuvant treatment group according to whether given adjuvant drugs to raise Tac trough concentrations. MDR1 C3435T and G2677T SNPs were detected by using sequence specific primers PCR.Tac trough concentrations of whole blood were measured by using enzymelabeled immunosorbent assay.Tac concentration-to-dose ratio (C/D) standardized by body weight was compared according to the various genotypes and haplotypes of MDR1 C3435T and G2677TA SNPs.Results Adjuvant treatment group including 36 recipients had a higher frequency of C genotype of C3435T than un-adjuvant treatment group (68.05％ vs 48.35％,P ＜ 0.01 ). The frequency of G2677TA polymorphisms was of no significant difference between the two group recipients (P＞ 0.05).As to non-adjuvant treatment recipients,the mean Tac DD required and C/D were not significantly different among various polymorphisms of MDR1 G2677T/A and C3435T or various haplotypes (P＞0.05).During A follow-up period of 4 years,13 recipients suffered graft dysfunction in which 84.6％ (11/13) carried 3435C genotype (P＞0.05).Conclusion The frequency of MDR1 C3435T polymorphisms in RTRs is high in the recipients given adjuvant treatment to raise Tac concentrations.Recipients with 3435C genotype were prone to graft dysfunction.
- [1]Viklicky O,Bandur S,Brabcova I,etc.Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.[J].2008,86(9).
- [2]Morita T,Ohtani H,Higuchi S,etc.Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.[J].2002,72(2).
- [3]Gaber AO,Wong ST,Razo J,etc.Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients.[J].2010,11(10).
- [4]Dauber J,McCurry K,Zeevi A,etc.The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients.[J].2005,14(1).
- [5]M H, Frank,M D, Denton,S I, Alexander,etc.Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro.[J].2001,166(4).
- [6]Hazzan M,Glowacki F,Broly F,etc.CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation.[J].2011,26(9).
- [7]Passey C,Birnbaum AK,Brundage RC,etc.Dosing equation for tacrolimus using genetic variants and clinical factors.[J].2011,72(6).
- [8]Singh R,Srivastava A,Kapoor R,etc.Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period?[J].2011,51(4).
- [9]Holt DW,Goldberg L,Fredericks S,etc.Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement.[J].2002,74(11).
- [10]Herrlinger KR,Koc H,Winter S,etc.ABCB1 single-nucleotide polymorphisms determine tacrolimus response in patients with ulcerative colitis.[J].2011,89(3).
- [11]Ni XJ,Zheng SL,Wu CZ.A fast SSP-PCR method for genotyping the ATP-binding cassette subfamily B member 1 gene C3435T and G2677T polymorphisms in Chinese transplant recipients.[J].2009,95(3).
- [12]Pravica V,Richardson S,Fildes J,etc.The MDR1/ABCB1 gene, a high-impact risk factor for cardiac transplant rejection.[J].2006,82(12).